Abstract
The presence of the water soluble glycerophospholipid precursors choline and inositol in culture media highly affects lipid biosynthesis and regulation thereof. We report that widely used media ingredients contain trace amounts of choline and inositol that are not mentioned on the product label, influencing experimental outcome.
Keywords: lipid metabolism, inositol, choline, Saccharomyces cerevisiae, soluble lipid precursors, culture medium ingredients
The authors report that widely used media ingredients contain trace amounts of inositol and/or choline that are not mentioned on the product label, possibly influencing experimental outcome.
Saccharomyces cerevisiae is a widely used model organism in research addressing lipid metabolism, lipid transport, and membrane homeostasis (Santos and Riezman 2012; Singh 2017). The biosynthesis of yeast phospholipids (PLs) is tightly regulated, and depends amongst others on the exogenous availability of inositol, ethanolamine and choline, which serve as precursors for the synthesis of phosphatidylinositol (PI), phosphatidylethanolamine and phosphatidylcholine, respectively (Henry, Kohlwein and Carman 2012). In addition to its role as the precursor of PI, inositol plays a key role in the regulation of PL biosynthesis via the regulation of the transcriptional activator complex Ino2/4p (Henry, Kohlwein and Carman 2012). In the absence of inositol, phosphatidic acid (PA) accumulates in the ER membrane retaining the PA sensor protein Opi1p tethered to the ER. Upon addition of inositol to the medium, PA is converted to PI, releasing Opi1p from the ER and allowing it to enter the nucleus. In the nucleus, Opi1p binds the Ino2/4p complex and attenuates the expression of genes activated by Ino2/4p. The sequence bound by Ino2/4p is known as the Upstream Activating Sequence inositol (UASINO). In addition to the role of inositol in the regulation of lipid metabolism, inositol has been implicated in regulation of various stress responses, including the unfolded protein response (Henry, Gaspar and Jesch 2014). In the presence of inositol, choline strongly influences lipid metabolism and its regulation (Henry, Kohlwein and Carman 2012).
Inositol and choline are known to influence lipid metabolism at very low concentrations. The Km of the choline transporter Hnm1p was found to be 0.56 µM (58 µg/L) (Hosaka and Yamashita 1980), thus sub mg/L contaminations of choline can already completely satiate choline import. Partial repression of INO1 (encoding inositol-6-phosphate synthase) by exogenous inositol was detected at 10 µM (≈ 1.8 mg/L; (Hirsch and Henry 1986), and it fully represses INO1 and co-regulated UASINO-genes at 75 µM (≈ 13.5 mg/L; Henry, Gaspar and Jesch 2014). Studies addressing aspects of lipid metabolism in yeast require chemically defined culture media that are devoid of water soluble lipid precursors (see e.g. (Griac, Swede and Henry 1996)), that are preferably mixed in house from pure chemicals of highest possible quality. We recently found that several agars used for the preparation of solid media contain contaminations with lipid precursors that may affect experimental outcome. This prompted us to examine the ingredients of our synthetic defined media for the presence of choline and inositol.
The presence of inositol and choline in culture medium is conveniently detected by a spot assay monitoring growth of strains that are auxotrophic for the respective compounds, i.e.ino1Δ (AID; Greenberg, Reiner and Henry 1982) and cho2∆opi3∆ (Patton-Vogt et al. 1997; Boumann et al. 2006) (Fig. 1A). Supplementation with exogenous inositol or choline rescued the growth of the auxotrophic strains as expected (Fig. 1A). The agar we used (Fluka 05038) appears to contain a trace amount of choline sufficient for modest growth of the cho2∆opi3∆ mutant in supposedly choline-free conditions.
Figure 1.

Detection of inositol and/or choline in culture media. Growth of wild type strains BY4741 (MATahis3Δ1 leu2Δ0 met15Δ0 ura3Δ0), BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0), and inositol- (AID; MATa/α ino1–13/ino1–13 ade1/ade1; (Greenberg, Reiner and Henry 1982)), and choline- (cho2∆opi3∆; BY4742 cho2::KanMX opi3::LEU2; (Boumann et al. 2006)) auxotrophic mutants on synthetic defined (SD) media supplemented with 75 μM inositol, or 1 mM choline as indicated (A), and on several commonly used media (B). After pre-culture to early log phase in YPD, cells were washed and serially diluted in sterile water (10−1 – 10−3 OD600 unit/mL); 4 μL aliquots were spotted and incubated at 30°C for 3 days. Synthetic defined media were prepared as described (Griac et al. 1996), except for the medium based on Yeast Nitrogen Base (Difco YNB), and contained 2% glucose (SD), 2% galactose (SGal) or 2% galactose and 1% raffinose (SGR) as carbon source. All plates were prepared using Fluka agar (05038), except for the plate prepared with Bacto Agar (as indicated). Data shown is representative of at least three biological replicates.
An important commercially available ingredient of synthetic defined medium, Yeast Nitrogen Base (YNB) without amino acids, is known to contain inositol (11 µM, Sherman 1991; Hanscho et al. 2012; Fig. 1B, Difco YNB). Therefore, YNB for use in inositol-free media is generally mixed in house (Fig. 1A) based on the recipe described by Sherman (1991). The widely used Bacto Agar (BD Diagnostics, Franklin Lakes, NJ) contains trace amounts of choline and inositol, allowing moderate growth of the inositol and choline auxotrophs (Fig. 1B, Bacto Agar). Synthetic Galactose Raffinose medium (SGR) is often used for overexpressing genes of interest from a GAL-promotor. Galactose (150610010) from Acros Organics (Geel, BE) contains trace amounts of choline (Fig. 1B, SGal), whereas raffinose (195675000) from Acros contains a contamination of choline that supports wild type-like growth of the choline auxotroph, in addition to a contamination with inositol (Fig. 1B, SGR).
Of note, the presence of these contaminations can vary between batches, as exemplified by the occurrence of choline contamination in agar (A7002) from Sigma-Aldrich (St. Louis, MO) in Fig. 2 (i–iv). Since several batches of agar A7002 we tested contained choline, we searched for an alternative. Agars 05038 from Sigma-Aldrich and A0917 from PanReac AppliChem (Darmstadt, DE) are essentially choline-free (Fig. 2v and vi), and do not contain detectable inositol (data not shown).
Figure 2.

Choline contamination in different agars. Serial dilutions of wild type (BY4742; MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) and the choline auxotrophic mutant (cho2∆opi3∆; BY4742 cho2::KanMX opi3::LEU2) on SD with or without 1 mM choline prepared with the agars specified below. After pre-culture to log phase in SD supplemented with 75 μM inositol and 1 mM choline, serial dilutions (10−1–10−3 OD600 unit/mL) were spotted and incubated at 30°C for 5 (i–iv) or 6 days (v–vi). Agars used from Sigma-Aldrich were: (i) A7002, Lot#069K0079; (ii) A7002, Lot#BCBF3876V; (iii) A7002, Lot#BCBR2864V; (iv) A7002, Lot#BCBT6029; (v) 05038, Lot#BCBT2721; and from PanReac AppliChem: (vi) A0917, Lot#7R011016. Data shown is representative of at least three biological replicates.
In addition to testing for contaminations with choline and inositol, the presence of ethanolamine, the water soluble precursor of phosphatidylethanolamine, can be detected using the ethanolamine auxotroph strain psd1Δpsd2Δdpl1Δ (Birner et al. 2001; Aaltonen et al. 2016).
Contaminations in bulk medium components as reported here may account for differences in experimental outcome obtained with similar lipid biosynthetic mutants by different laboratories. To avoid problems that may arise from overlooked contaminants, we recommend the use of completely defined synthetic media based on in house mixed YNB, and regular control experiments to verify the absence of relevant contaminants in culture media. Furthermore, we stress the importance of listing the used media ingredients in detail in the methods section of articles.
ACKNOWLEDGEMENTS
The authors thank Dr. Steven Claypool, Dr. Jodi Nunnari, Dr. Vanina Zaremberg and Dr. Miriam Greenberg for useful discussions, and Dr. Susan Henry for providing strains. This work was supported by the Division of Chemical Sciences in the Netherlands (M.F.R.), with financial aid from the Netherlands Organization for Scientific Research (NWO) [project number 711.013.004] and the Chinese Scholarship Council (X.B.) [grant number 201204910146].
Contributor Information
Mike F Renne, Utrecht University, Membrane Biochemistry & Biophysics, Department of Chemistry, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Xue Bao, Utrecht University, Membrane Biochemistry & Biophysics, Department of Chemistry, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Anton I P M de Kroon, Utrecht University, Membrane Biochemistry & Biophysics, Department of Chemistry, Padualaan 8, 3584 CH, Utrecht, The Netherlands.
Conflict of interest
None declared.
REFERENCES
- Aaltonen MJ, Friedman JR, Osman Cet al.. MICOS and phospholipid transfer by Ups2-Mdm35 organize membrane lipid synthesis in mitochondria. J Cell Biol. 2016;213:525–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Birner R, Bürgermeister M, Schneiter Ret al.. Roles of phosphatidylethanolamine and of its several biosynthetic pathways in Saccharomyces cerevisiae. Mol Biol Cell. 2001;12:997–1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boumann HA, Gubbens J, Koorengevel MCet al.. Depletion of phosphatidylcholine in yeast induces shortening and increased saturation of the lipid acyl chains: evidence for regulation of intrinsic membrane curvature in a eukaryote. Mol Biol Cell. 2006;17:1006–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greenberg ML, Reiner B, Henry SA. Regulatory mutations of inositol biosynthesis in yeast: isolation of inositol-excreting mutants. Genetics. 1982;100:19–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Griac P, Swede MJ, Henry SA. The role of phosphatidylcholine biosynthesis in the regulation of the INO1 gene of yeast. J Biol Chem. 1996;271:25692–8. [DOI] [PubMed] [Google Scholar]
- Hanscho M, Ruckerbauer DE, Chauhan Net al.. Nutritional requirements of the BY series of Saccharomyces cerevisiae strains for optimum growth. FEMS Yeast Res. 2012;12:796–808. [DOI] [PubMed] [Google Scholar]
- Henry SA, Gaspar ML, Jesch SA. The response to inositol: regulation of glycerolipid metabolism and stress response signaling in yeast. Chem Phys Lipids. 2014;180:23–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henry SA, Kohlwein SD, Carman GM. Metabolism and regulation of glycerolipids in the yeast Saccharomyces cerevisiae. Genetics. 2012;190:317–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirsch JP, Henry SA. Expression of the Saccharomyces cerevisiae inositol-1-phosphate synthase (INO1) gene is regulated by factors that affect phospholipid synthesis. Mol Cell Biol. 1986;6:3320–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hosaka K, Yamashita S. Choline transport in Saccharomyces cerevisiae. J Bacteriol. 1980;143:176–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patton-Vogt JL, Griac P, Sreenivas Aet al.. Role of the yeast phosphatidylinositol/phosphatidylcholine transfer protein (Sec14p) in phosphatidylcholine turnover and INO1 regulation. J Biol Chem. 1997;272:20873–83. [DOI] [PubMed] [Google Scholar]
- Santos AXS, Riezman H. Yeast as a model system for studying lipid homeostasis and function. FEBS Lett. 2012;586:2858–67. [DOI] [PubMed] [Google Scholar]
- Sherman F. Getting started with yeast. Methods Enzymol. 1991;194:3–21. [DOI] [PubMed] [Google Scholar]
- Singh P. Budding yeast: an ideal backdrop for in vivo lipid biochemistry. Front Cell Dev Biol. 2017;4:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
